Post-Operative Pain - Pipeline Review, H2 2018

Post-Operative Pain - Pipeline Review, H2 2018

Summary

Global Markets Directs latest Pharmaceutical and Healthcare disease pipeline guide Post-Operative Pain - Pipeline Review, H2 2018, provides an overview of the Post-Operative Pain (Central Nervous System) pipeline landscape.

Pain is one of the main postoperative adverse outcomes causing distress to patients. Degree of postoperative pain experienced by individuals varies. Cause of pain includes peripheral nerve damage during surgery, inflammation at the site of the wound and damage to bodily tissues during surgery. Risk factors include site of the operation, age, level of fear or anxiety, surgical procedure, personal preference and response to agents given. Treatment for post-operative pain includes analgesia and anesthetics.

Report Highlights

Global Markets Directs Pharmaceutical and Healthcare latest pipeline guide Post-Operative Pain - Pipeline Review, H2 2018, provides comprehensive information on the therapeutics under development for Post-Operative Pain (Central Nervous System), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The guide covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases.

The Post-Operative Pain (Central Nervous System) pipeline guide also reviews of key players involved in therapeutic development for Post-Operative Pain and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies /Universities /Institutes, the molecules developed by Companies in Pre-Registration, Filing rejected/Withdrawn, Phase III, Phase II, Phase I, IND/CTA Filed, Preclinical, Discovery and Unknown stages are 4, 2, 8, 18, 8, 3, 19, 3 and 4 respectively. Similarly, the Universities portfolio in Phase III and Preclinical stages comprises 1 and 1 molecules, respectively.

Post-Operative Pain (Central Nervous System) pipeline guide helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage. The guide is built using data and information sourced from Global Markets Directs proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis.

Note: Certain content / sections in the pipeline guide may be removed or altered based on the availability and relevance of data.

Scope

- The pipeline guide provides a snapshot of the global therapeutic landscape of Post-Operative Pain (Central Nervous System).
- The pipeline guide reviews pipeline therapeutics for Post-Operative Pain (Central Nervous System) by companies and universities/research institutes based on information derived from company and industry-specific sources.
- The pipeline guide covers pipeline products based on several stages of development ranging from pre-registration till discovery and undisclosed stages.
- The pipeline guide features descriptive drug profiles for the pipeline products which comprise, product description, descriptive licensing and collaboration details, R&D brief, MoA & other developmental activities.
- The pipeline guide reviews key companies involved in Post-Operative Pain (Central Nervous System) therapeutics and enlists all their major and minor projects.
- The pipeline guide evaluates Post-Operative Pain (Central Nervous System) therapeutics based on mechanism of action (MoA), drug target, route of administration (RoA) and molecule type.
- The pipeline guide encapsulates all the dormant and discontinued pipeline projects.
- The pipeline guide reviews latest news related to pipeline therapeutics for Post-Operative Pain (Central Nervous System)

Reasons to buy

- Procure strategically important competitor information, analysis, and insights to formulate effective R&D strategies.
- Recognize emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage.
- Find and recognize significant and varied types of therapeutics under development for Post-Operative Pain (Central Nervous System).
- Classify potential new clients or partners in the target demographic.
- Develop tactical initiatives by understanding the focus areas of leading companies.
- Plan mergers and acquisitions meritoriously by identifying key players and its most promising pipeline therapeutics.
- Formulate corrective measures for pipeline projects by understanding Post-Operative Pain (Central Nervous System) pipeline depth and focus of Indication therapeutics.
- Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and Scope.
- Adjust the therapeutic portfolio by recognizing discontinued projects and understand from the know-how what drove them from pipeline.


Introduction 5
Post-Operative Pain - Overview 6
Post-Operative Pain - Therapeutics Development 7
Post-Operative Pain - Therapeutics Assessment 18
Post-Operative Pain - Companies Involved in Therapeutics Development 28
Post-Operative Pain - Drug Profiles 49
Post-Operative Pain - Dormant Projects 208
Post-Operative Pain - Discontinued Products 212
Post-Operative Pain - Product Development Milestones 213
Appendix 223

List Of Tables

List of Tables
Number of Products under Development for Post-Operative Pain, H2 2018
Number of Products under Development by Companies, H2 2018
Number of Products under Development by Companies, H2 2018 (Contd..1), H2 2018
Number of Products under Development by Companies, H2 2018 (Contd..2), H2 2018
Number of Products under Development by Universities/Institutes, H2 2018
Products under Development by Companies, H2 2018
Products under Development by Companies, H2 2018 (Contd..1), H2 2018
Products under Development by Companies, H2 2018 (Contd..2), H2 2018
Products under Development by Companies, H2 2018 (Contd..3), H2 2018
Products under Development by Universities/Institutes, H2 2018
Number of Products by Stage and Target, H2 2018
Number of Products by Stage and Target, H2 2018 (Contd..1), H2 2018
Number of Products by Stage and Mechanism of Action, H2 2018
Number of Products by Stage and Mechanism of Action, H2 2018 (Contd..1), H2 2018
Number of Products by Stage and Route of Administration, H2 2018
Number of Products by Stage and Molecule Type, H2 2018
Post-Operative Pain - Pipeline by Abide Therapeutics Inc, H2 2018
Post-Operative Pain - Pipeline by AcelRx Pharmaceuticals Inc, H2 2018
Post-Operative Pain - Pipeline by Adynxx Inc, H2 2018
Post-Operative Pain - Pipeline by AngioChem Inc, H2 2018
Post-Operative Pain - Pipeline by Aoxing Pharmaceutical Company Inc, H2 2018
Post-Operative Pain - Pipeline by Apsen Farmaceutica SA, H2 2018
Post-Operative Pain - Pipeline by Cadila Healthcare Ltd, H2 2018
Post-Operative Pain - Pipeline by Camurus AB, H2 2018
Post-Operative Pain - Pipeline by Cara Therapeutics Inc, H2 2018
Post-Operative Pain - Pipeline by Center Laboratories Inc, H2 2018
Post-Operative Pain - Pipeline by CerSci Therapeutics Inc, H2 2018
Post-Operative Pain - Pipeline by Colby Pharmaceutical Co, H2 2018
Post-Operative Pain - Pipeline by Dompe Farmaceutici SpA, H2 2018
Post-Operative Pain - Pipeline by Eupraxia Pharmaceuticals Inc, H2 2018
Post-Operative Pain - Pipeline by EyeGate Pharmaceuticals Inc, H2 2018
Post-Operative Pain - Pipeline by Fujimoto Pharmaceutical Corp, H2 2018
Post-Operative Pain - Pipeline by GW Pharmaceuticals Plc, H2 2018
Post-Operative Pain - Pipeline by Heron Therapeutics Inc, H2 2018
Post-Operative Pain - Pipeline by Immupharma Plc, H2 2018
Post-Operative Pain - Pipeline by Innocoll AG, H2 2018
Post-Operative Pain - Pipeline by Insys Therapeutics Inc, H2 2018
Post-Operative Pain - Pipeline by Ionis Pharmaceuticals Inc, H2 2018
Post-Operative Pain - Pipeline by iX Biopharma Ltd, H2 2018
Post-Operative Pain - Pipeline by Jiangsu Hengrui Medicine Co Ltd, H2 2018
Post-Operative Pain - Pipeline by Lipocure Ltd, H2 2018
Post-Operative Pain - Pipeline by Liquidia Technologies Inc, H2 2018
Post-Operative Pain - Pipeline by Lumosa Therapeutics Co Ltd, H2 2018
Post-Operative Pain - Pipeline by Medtronic Plc, H2 2018
Post-Operative Pain - Pipeline by Mundipharma International Ltd, H2 2018
Post-Operative Pain - Pipeline by Neumentum Inc, H2 2018
Post-Operative Pain - Pipeline by Novartis AG, H2 2018
Post-Operative Pain - Pipeline by Ocular Therapeutix Inc, H2 2018
Post-Operative Pain - Pipeline by Pacira Pharmaceuticals Inc, H2 2018
Post-Operative Pain - Pipeline by PainReform Ltd, H2 2018
Post-Operative Pain - Pipeline by Pharmaleads SA, H2 2018
Post-Operative Pain - Pipeline by PhytoHealth Corp, H2 2018
Post-Operative Pain - Pipeline by PixarBio Corp, H2 2018
Post-Operative Pain - Pipeline by PolyPid Ltd, H2 2018
Post-Operative Pain - Pipeline by RaQualia Pharma Inc, H2 2018
Post-Operative Pain - Pipeline by Recro Pharma Inc, H2 2018
Post-Operative Pain - Pipeline by Serina Therapeutics Inc, H2 2018
Post-Operative Pain - Pipeline by SteadyMed Therapeutics Inc, H2 2018
Post-Operative Pain - Pipeline by Taiwan Liposome Company Ltd, H2 2018
Post-Operative Pain - Pipeline by Teikoku Pharma USA Inc, H2 2018
Post-Operative Pain - Pipeline by Trevena Inc, H2 2018
Post-Operative Pain - Pipeline by Virpax Pharmaceuticals Inc, H2 2018
Post-Operative Pain - Pipeline by Xigen SA, H2 2018
Post-Operative Pain - Pipeline by YiChang Humanwell Pharmaceutical Co Ltd, H2 2018
Post-Operative Pain - Dormant Projects, H2 2018
Post-Operative Pain - Dormant Projects, H2 2018 (Contd..1), H2 2018
Post-Operative Pain - Dormant Projects, H2 2018 (Contd..2), H2 2018
Post-Operative Pain - Dormant Projects, H2 2018 (Contd..3), H2 2018
Post-Operative Pain - Discontinued Products, H2 2018

List Of Figures

List of Figures
Number of Products under Development for Post-Operative Pain, H2 2018
Number of Products under Development by Companies, H2 2018
Number of Products under Development by Universities/Institutes, H2 2018
Number of Products by Top 10 Targets, H2 2018
Number of Products by Stage and Top 10 Targets, H2 2018
Number of Products by Top 10 Mechanism of Actions, H2 2018
Number of Products by Stage and Top 10 Mechanism of Actions, H2 2018
Number of Products by Top 10 Routes of Administration, H2 2018
Number of Products by Stage and Top 10 Routes of Administration, H2 2018
Number of Products by Molecule Types, H2 2018
Number of Products by Stage and Molecule Types, H2 2018

Post-Operative Pain Global Clinical Trials Review, H1, 2018

Post-Operative Pain Global Clinical Trials Review, H1, 2018The clinical trial report, Post-Operative Pain Global Clinical Trials Review, H1, 2018 provides an overview of Post-Operative Pain clinical trials scenario. This report

USD 2500 View Report

Post-Operative Pain - Pipeline Review, H2 2018

Post-Operative Pain - Pipeline Review, H2 2018Global Markets Directs latest Pharmaceutical and Healthcare disease pipeline guide Post-Operative Pain - Pipeline Review, H2 2018, provides an overview of the Post-Operative Pain

USD 2000 View Report

Strategic Market Intelligence: Reinsurance in Spain - Key Trends and Opportunities to 2021

Strategic Market Intelligence: Reinsurance in Spain - Key Trends and Opportunities to 2021The Strategic Market Intelligence: Reinsurance in Spain - Key Trends and Opportunities to 2021 report provides a detailed

USD 3999 View Report

Strategic Market Intelligence: General Insurance in Spain - Key Trends and Opportunities to 2021

Strategic Market Intelligence: General Insurance in Spain - Key Trends and Opportunities to 2021The Strategic Market Intelligence: General Insurance in Spain - Key Trends and Opportunities to 2021 report provides

USD 3999 View Report

Your are not allow to send sample request

Fill The Form For Sample Request

Note : * Kindly provide us with your company id and get the sample reports at the earliest.

There is no Reviews available